02 Jul 2021 --- In nutrition news this week, Seres Therapeutics joined Nestlé Health Science to commercialize what could become the first-ever FDA-approved microbiome therapeutic. Phynova Group and Lus Health Ingredients partnered to promote mulberry leaf extract Reducose, and CBD company Kadenwood raised US$50 million of cash and media value in a series B fundraising round.
